The targeting of NOX2 by systemic treatment with the NOX2 transduction inhibitor histamine dihydrochloride (HDC) reduced the formation of lung melanoma metastases in wild-type but not in Nox2-deficient mice. This evidence concerns the gene CYBB and medical procedure.